Phospholipid curcumin Meriva Promising in Treatment of Nonalcoholic Steatohepatitis and Kidney Disease: Study Dr Riya Dave9 July 2024 7:45 AM ISTResearchers recently have found that Meriva, a phospholipid formulation of curcumin, is both safe and effective in improving liver histology, kidney...
DASH Diet reveals Significant Benefits for Liver Health for Patients with NAFLD Chumbeni6 Jan 2024 9:15 AM IST In a recent randomized controlled trial, researchers investigated the potential effect of the Dietary approaches to stop hypertension...
Standard of Care in Diabetes 2024: ADA update emphasises screening people with diabetes for NAFLD and NASH Medha Baranwal25 Dec 2023 9:00 AM ISTUSA: The American Diabetes Association (ADA) has released Standards of Care in Diabetes-2024 which includes the ADA's current clinical practice...
Investigational FGF21 analogue improves fibrosis in NASH patients: Phase 2b trial Medha Baranwal27 Jun 2023 11:00 AM ISTUSA: Treatment with an investigational FGF21 analogue, pegozafermin, improved fibrosis in patients with NASH (nonalcoholic steatohepatitis), according...
Semaglutide 2.4 mg fails to significantly improve fibrosis, achieve resolution of NASH Dr. Shravani Dali28 March 2023 11:15 AM ISTAccording to new phase 2 trial results, Once-weekly semaglutide 2.4 mg fails to significantly improve fibrosis or achieve resolution of non-alcoholic...
Novo Nordisk, Ventus Therapeutics collaborate for NLRP3 Inhibitor Program Ruchika Sharma5 Oct 2022 11:00 AM ISTVentus retains the right to develop NLRP3 inhibitors for certain systemic diseases, including specific inflammatory and respiratory diseases.
Visceral Fat Volume correlates with Hepatic Fibrosis in NAFLD Patients Isra Zaman8 Sept 2022 10:00 AM ISTStudy in JAPI aimed to calculate visceral fat volume at the L3-L4 vertebral level and its association with hepatic fibrosis assessed by transient...
Vitamin B12 and folic acid may reverse liver inflammation and fibrosis in severe NAFLD: JAMA Dr. Kamal Kant Kohli8 Aug 2022 9:15 AM ISTScientists at Duke-NUS Medical School in Singapore have uncovered a mechanism that leads to an advanced form of fatty liver disease-and it turns out...
Researchers Create Highly Accurate Non-Invasive Test for Major Liver Diseases Dr. Kamal Kant Kohli16 July 2022 12:30 AM ISTResearchers have created a liquid biopsy test, which uses two circulating proteins, to test for major liver diseases. The test was found to be highly...
Anti-diabetic drug and NASH: Current Options in 2022 Dr. Kamal Kant Kohli9 Jun 2022 11:06 AM ISTIntroduction and Background Nonalcoholic steatohepatitis (NASH) is a more aggressive form of nonalcoholic fatty liver disease, which can increase the...
Pfizer gets USFDA Fast Track Designation for Ervogastat plus Clesacostat to treat NASH Ruchika Sharma28 May 2022 11:57 AM ISTDiacylglycerol O-acyltransferase 2 (DGAT2) and acetyl-CoA carboxylase (ACC) are two key enzymes that regulate lipid metabolism. Inhibitors of ACC and...
Saroglitazar beneficial for treatment of patients with NAFLD/NASH: Study Medha Baranwal16 Oct 2021 10:15 AM ISTUSA: The administration of Saroglitazar 4 mg significantly improves liver parameters and histology and reduces the risk of cardiovascular disease in...
